June 1, 2009
By:Peter O'Donnell
EMEA releases new guideline for studies in PTSD, as new figures depict a lagging EU.
 |
May 1, 2009
By:Peter O'Donnell
Changing rules on advanced therapy medicinal products to require more from clinical studies.
|
April 1, 2009
By:Peter O'Donnell
As EU debates plans for advancing R&D in rare diseases, industry assesses the risks and benefits.
|
March 1, 2009
By:Peter O'Donnell
Ten-year-old study sets precedent for future collaborative observational studies on drug safety.
|
February 1, 2009
By:Peter O'Donnell
What to expect from the new leadership and why there's not much hope for an improved directive.
|
January 1, 2009
By:Peter O'Donnell
What antitrust authorities have uncovered so far in their search for sabotage.
|
December 1, 2008
By:Peter O'Donnell
Along with the titles and phone numbers of personnel, View from Brussels columnist Peter O'Donnell provides an update on the regulatory front in Europe.
|
November 1, 2008
By:Peter O'Donnell
Animal use in clinical trials comes into question as Europe debates an update of current rules.
|
October 1, 2008
By:Peter O'Donnell
The EU provides extensive funds to the clinical trials industry in an effort to better health care delivery.
|
| 
